Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2012
05/03/2012CA2819117A1 Anti-sod1 antibodies and uses thereof
05/03/2012CA2816054A1 Methods and compositions suitable for promoting healthy skin
05/03/2012CA2816052A1 Liquid formulations of long acting interferon alpha conjugate
05/03/2012CA2815582A1 Treatment of mecp2-associated disorders
05/03/2012CA2815419A1 Treating diabetes melitus using insulin injections administered with varying injection intervals
05/03/2012CA2815239A1 Fviii peptides for immune tolerance induction and immunodiagnostics
05/03/2012CA2815237A1 Method of improving transplant function using soluble complement receptor type i (scr1)
05/03/2012CA2813833A1 Liposome-based construct comprising a peptide modified through hydrophobic moieties
05/03/2012CA2785887A1 Composition comprising a combination of at least one proteolytic enzyme and at least one lipolytic enzyme, for use in preventing triglyceride synthesis
05/02/2012EP2447370A1 MicroRNA molecules
05/02/2012EP2447369A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447368A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447367A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447280A2 VEGF analogs and methods of use
05/02/2012EP2446902A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446901A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446900A1 Methods for treating conditions associated with MASP-2 dependent complement activation
05/02/2012EP2446898A1 Use of growth hormone to enhance the immune response in immunosuppressed patients
05/02/2012EP2446897A1 Anti-KIR combination treatments and methods
05/02/2012EP2446896A1 Activin-ActRII Antagonists for use in Increasing Red Blood Cells, increasing reticulocyte levels, or promoting erythropoiesis
05/02/2012EP2446895A1 EPH receptor expression in tumor stem cells
05/02/2012EP2446894A2 Adrenocorticotropic hormone analogs and related methods
05/02/2012EP2446893A1 Use of nontoxic cyclic peptides to block transport via OATP1B1/ OATP1B3-related proteins, for the treatment of cancer cells expressing such transporters
05/02/2012EP2446890A1 High viscosity macromolecular compositions for treating ocular conditions
05/02/2012EP2446034A1 Novel polynucleotide molecules for enhanced gene expression
05/02/2012EP2446031A1 Stabilizing alkylglycoside compositions and methods thereof
05/02/2012EP2445933A1 Avian colony stimulating factor 1 receptor binding proteins
05/02/2012EP2445927A1 Lipidated tumor- associated antigens and immunotherapeutic compositions
05/02/2012EP2445859A2 Method for isolating cimiracemate a
05/02/2012EP2445533A1 Method for treating or ameliorating mucocutaneous or ocular toxicities
05/02/2012EP2445529A2 Marker differentially expressed in cancer stem cells and methods of using same
05/02/2012EP2445517A1 Methods for diagnosing irritable bowel syndrome
05/02/2012EP2445516A1 Factor vii composition
05/02/2012EP2445515A2 Antimicrobial agents
05/02/2012EP2445514A1 Methods for assessing tophus response during urate lowering therapy in treatment tophaceous gout
05/02/2012EP2445513A1 Chimeric factor vii molecules
05/02/2012EP2445512A2 Enhancement of bmp retention
05/02/2012EP2445511A2 Skin repair compositions comprising circadian gene activators and a synergistic combination of sirt1 gene activators
05/02/2012EP2445510A1 Compositions for treating degenerative joint diseases
05/02/2012EP2445509A1 Zinc supplementation to increase responsiveness to metalloprotease therapy
05/02/2012EP2445505A1 Combined use of creatine phosphate and creatine phosphokinase for treatment of arteriosclerosis
05/02/2012EP2445482A1 Method for preparing an enriched igg composition from plasma
05/02/2012EP2445407A2 A method and device for improving glycemic control based on residual insulin
05/02/2012EP2445339A1 Diffusion enhancing compounds and their use alone or with thrombolytics
05/02/2012EP2234645B1 Peg-interferon-beta formulations
05/02/2012EP2178900B1 Purification of pegylated polypeptides
05/02/2012EP2124993B1 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use
05/02/2012EP2026832B1 Combination of interferon-beta and a cladribine regimen for treating multiple sclerosis
05/02/2012EP1702064B1 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
05/02/2012EP1678200B1 A method of modulating cell survival, differentiation and/or synaptic plasticity
05/02/2012EP1634951B1 Novel protein
05/02/2012EP1549246B1 Antibiotic micropheres for treatment of infections and osteomyelitis
05/02/2012EP1507796B1 Cross-linked glycopeptide-cephalosporin antibiotics
05/02/2012EP1429723B1 Treating effects of excessive reactive oxygen species
05/02/2012EP1418893B1 Compositions and techniques for localized therapy of restenosis
05/02/2012EP1399133B2 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same
05/02/2012EP1389130B1 Use of osteopontin for the treatment and/or prevention of neurologic diseases
05/02/2012EP1343822B1 Means for the diagnosis and therapy of ctcl
05/02/2012EP1256348B1 Remedies for hepatitis c
05/02/2012EP1185248B1 Supercritical fluid-assisted nebulization and bubble drying
05/02/2012CN102439153A Compositions for stimulation of mammalian innate immune resistance to pathogens
05/02/2012CN102439041A Modulation of the vps 10-domain receptor family for the treatment of mental and behavioural disorders
05/02/2012CN102439034A Bifunctional polypeptides
05/02/2012CN102439028A Influenza a and b virus replication-inhibiting peptides
05/02/2012CN102438654A Methods and compositions for treating lupus
05/02/2012CN102438648A Tissue kallikrein for the treatment of pancreatic beta-cell dysfunction
05/02/2012CN102438647A Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor
05/02/2012CN102438646A Treatment of metastatic tumors
05/02/2012CN102438645A Therapeutic modulation of vaginal epithelium boundary lubrication
05/02/2012CN102438643A Compositions and methods for treatment of celiac disease
05/02/2012CN102438604A Agent for the prophylaxis and treatment of highly pathogenic infectious diseases
05/02/2012CN102438602A An improved dry powder drug delivery system
05/02/2012CN102433314A Recombinant fenneropenaeus merguiensis lysozyme, as well as preparation and application thereof
05/02/2012CN102432675A Novel polypeptide compound
05/02/2012CN102432672A Novel synthesis antibacterial peptides and application thereof
05/02/2012CN102432671A Targeting polypeptide SPSCVLP capable of inhibiting growth and transfer of liver cancer and application thereof
05/02/2012CN102432670A Silkworm chrysalis protein source dipeptide SS and application thereof
05/02/2012CN102432511A Facially amphiphilic polymers and oligomers and uses thereof
05/02/2012CN102430129A Bone morphogenetic protein-2/basic fibroblast growth factor (BMP-2/bFGF) double-gene chitosan nano-microcapsules and application thereof
05/02/2012CN102430119A Construction method of drug evaluation model for dermal pathology of tuberculosis rabbit
05/02/2012CN102430117A Modified proteases that inhibit complement activation
05/02/2012CN102430116A Dry heat treatment method for human coagulation factor VIII preparation and dry heat treatment stabilizer
05/02/2012CN102430115A Compound propolis composition for treating porcine circovirus disease and preparation method thereof
05/02/2012CN102430114A Compound propolis composition for treating porcine parvovirus disease and preparation method thereof
05/02/2012CN102430113A Compound propolis composition for treating porcine pseudorabies and preparation method thereof
05/02/2012CN102430112A Atomization inhalant prepared from interferon alpha and salbutamol sulfate
05/02/2012CN102430111A Epitopes related to coeliac disease
05/02/2012CN102430110A CAlprostadil composite medicament of compound fermented cordyceps sinensis powder and alprostadil composite drug
05/02/2012CN102430109A Amlodipine, aliskiren and pril compound antihypertensive medicament
05/02/2012CN102429891A Method for preparing low-molecular-weight sheep bone collagen polypeptide calcium chelate microcapsules
05/02/2012CN102429890A Medicinal composition containing cells and application thereof
05/02/2012CN102429876A Liraglutide sustained-release microsphere preparation and preparation method thereof
05/02/2012CN102429875A Cyclosporin A pulmonary inhaled macroporous microspheres and preparation method thereof
05/02/2012CN102429858A Preparation method and application of sustained-release BIO/IGF (6-bromoindirubin-3'-oxime/insulin-like growth factor) composite hydrogel
05/02/2012CN102429830A Method for extracting biological active peptide from animal placenta
05/02/2012CN101892240B Japanese blood fluke beta-catenin gene, protein and application
05/02/2012CN101892177B Antifungal lipopeptid-containing skin liniment and preparation method thereof
05/02/2012CN101805392B Anti-inflammatory antibacterial polypeptide capable of blocking combination of LPS and MD2
05/02/2012CN101732703B Composition for antagonizing pyretic effect of endotoxin in vaccine on livestock and application thereof
05/02/2012CN101721690B Application of PTD-SOD fusion protein in anti-intoxication alcohol neutralizing product
1 ... 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 ... 3163